慢性粒细胞白血病中JAK2-V617F突变的研究进展 - Suppr

Insights into JAK2-V617F mutation in CML.

作者信息

Büsche Guntram, Hussein Kais, Bock Oliver, Kreipe Hans

出版信息

Lancet Oncol. 2007 Oct;8(10):863-4. doi: 10.1016/S1470-2045(07)70294-2.

DOI:10.1016/S1470-2045(07)70294-2

PMID:17913656

Abstract

摘要

相似文献

Insights into JAK2-V617F mutation in CML.

Lancet Oncol. 2007 Oct;8(10):863-4. doi: 10.1016/S1470-2045(07)70294-2.

Insights into JAK2-V617F mutation in CML.

Lancet Oncol. 2007 Oct;8(10):864-6. doi: 10.1016/S1470-2045(07)70295-4.

JAK2-V617F and BCR-ABL--double jeopardy?

Leuk Res. 2008 Oct;32(10):1489-90. doi: 10.1016/j.leukres.2008.03.011. Epub 2008 Apr 24.

Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations.

J Clin Pathol. 2016 Aug;69(8):713-9. doi: 10.1136/jclinpath-2015-203498. Epub 2016 Jan 11.

Clinical and laboratory relevance of JAK2 V617F and BCR-ABL co-existence in Philadelphia positive CML patients.

Pak J Pharm Sci. 2021 Nov;34(6(Supplementary)):2289-2295.

The incidence of co-existing BCR-ABL1 and JAK2 V617F rearrangements: implications for molecular diagnostics.

Lab Hematol. 2012 Dec;18(4):20-1. doi: 10.1532/LH96.12009.

Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation.

Int J Hematol. 2014 Jan;99(1):87-90. doi: 10.1007/s12185-013-1480-z. Epub 2013 Nov 30.

Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia.

Int J Hematol. 2008 Sep;88(2):243-245. doi: 10.1007/s12185-008-0131-2. Epub 2008 Jul 16.

Lipocalin-2 is associated with modulation of disease phenotype in a patient with concurrent JAK2-V617F and BCR-ABL mutation.

Eur J Haematol. 2012 Feb;88(2):175-8. doi: 10.1111/j.1600-0609.2011.01712.x. Epub 2011 Nov 17.

Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation.

Leukemia. 2008 May;22(5):1059-62. doi: 10.1038/sj.leu.2404993. Epub 2007 Nov 1.

引用本文的文献

Two CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic remission after treatment with imatinib mesylate.

Int J Hematol. 2013 Jun;97(6):804-7. doi: 10.1007/s12185-013-1326-8. Epub 2013 Apr 24.

[Precursors of acute leukemia: myelodysplastic syndromes and myeloproliferative neoplasms].

Pathologe. 2011 Nov;32 Suppl 2:271-6. doi: 10.1007/s00292-011-1504-5.

[Chronic myeloid neoplasms. Diagnostic criteria and current therapeutic concepts].

Pathologe. 2010 Feb;31(1):29-41. doi: 10.1007/s00292-009-1261-x.

Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia.

Int J Hematol. 2008 Sep;88(2):243-245. doi: 10.1007/s12185-008-0131-2. Epub 2008 Jul 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Insights into JAK2-V617F mutation in CML.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献